ROAN News and Press, Roan Resources Inc. Class A

"I cannot hate thee worser than I do..." - William Shakespeare, Antony and Cleopatra I know, right? What better way to start out an article on a review of the E&P sector than by referencing a quote from Shakespeare? I can see many readers already shaking their heads: "Worser" is not ev...

Merger activity increased with five new deals announced and five deals closing. Deal Statistics New Deals The acquisition of Audentes Therapeutics (BOLD) by Astellas Pharma (ALPMF) for $2.65 billion or $60.00 per share in cash. The acquisition of AK Steel Holding Corporation...

NEW YORK, NY / ACCESSWIRE / November 22, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Roan Resources, Inc (NYSE: ROAN ) related...

NEW YORK , Nov. 22, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law rel...

Roan Resources ( ROAN ) reported solid Q3 2019 production results , indicating that its merge acreage looks capable of generating decent returns for Citizen Energy in the future. Due to the relatively low oil percentage of most of the merge wells though, realized prices for natural gas and NG...

Roan Resources (NYSE: ROAN ): Q3 GAAP EPS of $0.13 in-line. More news on: Roan Resources, Inc., Earnings news and commentary, Energy stocks news, , Read more ...

Roan Resources, Inc. (NYSE: ROAN) (“Roan” or the “Company”) today announced third quarter 2019 operating and financial results. Merger with Citizen Energy On October 1, 2019, the Company entered into an Agreement and Plan of Merger (the “Merger A...

Roan Resources ( ROAN ) announced that it was selling itself for approximately $1 billion, including the assumption of $780 million in debt. Shareholders are receiving around $1.52 per share in cash (a 24% premium to Roan's prior closing price). This deal appears to be fair given the compa...

NEW YORK, NY / ACCESSWIRE / October 23, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Achillion Pharmaceuticals, Inc (NASDAQ: ACHN ...

NEW YORK, NY / ACCESSWIRE / October 19, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Ra Pharmaceuticals, Inc . ( RARX ) related to i...